BAR As a Mortality Predictor in Septic AKI
The Role of Blood Urea Nitrogen to Serum Albumin Ratio in the Prediction of Mortality in Septic Acute Kidney Injury Patients
1 other identifier
observational
64
1 country
1
Brief Summary
The aim of this study is to investigate the prognostic value of Blood Urea Nitrogen to serum Albumin ratio in septic Acute Kidney Injury patients Follow-up will be conducted for all enrolled patients for 30 days from admission to record mortality and the cause of death.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 25, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedFirst Submitted
Initial submission to the registry
August 24, 2024
CompletedFirst Posted
Study publicly available on registry
September 4, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 25, 2024
CompletedFebruary 17, 2025
July 1, 2024
8 months
August 24, 2024
February 14, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
mortality
number of cases of mortality
30 days
Secondary Outcomes (5)
mechanical ventilation
30 days
stage-3 AKI
30 days
renal replacement therapy
30 days
septic shock
30 days
length of ICU stay
30 days
Eligibility Criteria
This prospective study will be conducted on patients with septic acute kidney injury. After admission of the patient to ICU in Ain Shams University Hospitals
You may qualify if:
- years of age
- Fulfilled the diagnostic criteria of Sepsis 3.0 (defined as a suspected or confirmed infection with a sequential organ failure assessment (SOFA) score of 2 or higher)
- Developed AKI during hospitalization according to Kidney Disease: Improving Global Outcomes (KDIGO) guideline
You may not qualify if:
- ICU length of stay\<24 h
- AKI occurred before current hospital admission.
- AKI is supposed to be secondary to causes other than sepsis.
- Receiving renal replacement therapy at the time of admission.
- Diagnosis with chronic kidney disease.
- Diagnosis with liver failure.
- Pregnant or lactating.
- There was insufficient data for analysis.
- Patients who had received Human serum Albumin infusion 3 days before ICU admission.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ain Shams University
Cairo, Abbassia, 11566, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 24, 2024
First Posted
September 4, 2024
Study Start
September 25, 2023
Primary Completion
June 1, 2024
Study Completion
September 25, 2024
Last Updated
February 17, 2025
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share